Print Version
Considerations for the New Four-Month Rifapentine-Moxifloxacin Regimen for Drug-Susceptible TB in the U.S.
Author:
Rutgers Global Tuberculosis Institute
Publication Date:
2021
Country of Origin:
United States
Format:
Webinar/Podcast
Language:
English
Abstract
Presented on September 21, 2021 by the TB Centers of Excellence and the Centers for Disease Control and Prevention
Publisher:
Global Tuberculosis Institute at Rutgers The State University of New Jersey
Audience(s):
Health Professionals
Topic:
TB Treatment
Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.